These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28499492)

  • 1. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.
    Halle S; Halle O; Förster R
    Trends Immunol; 2017 Jun; 38(6):432-443. PubMed ID: 28499492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical models of cytotoxic T-lymphocyte killing.
    Regoes RR; Yates A; Antia R
    Immunol Cell Biol; 2007 Jun; 85(4):274-9. PubMed ID: 17420769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human profilin 1 is a negative regulator of CTL mediated cell-killing and migration.
    Schoppmeyer R; Zhao R; Cheng H; Hamed M; Liu C; Zhou X; Schwarz EC; Zhou Y; Knörck A; Schwär G; Ji S; Liu L; Long J; Helms V; Hoth M; Yu X; Qu B
    Eur J Immunol; 2017 Sep; 47(9):1562-1572. PubMed ID: 28688208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general functional response of cytotoxic T lymphocyte-mediated killing of target cells.
    Gadhamsetty S; Marée AF; Beltman JB; de Boer RJ
    Biophys J; 2014 Apr; 106(8):1780-91. PubMed ID: 24739177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do mathematical models tell us about killing rates during HIV-1 infection?
    Gadhamsetty S; Beltman JB; de Boer RJ
    Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.
    Halle S; Keyser KA; Stahl FR; Busche A; Marquardt A; Zheng X; Galla M; Heissmeyer V; Heller K; Boelter J; Wagner K; Bischoff Y; Martens R; Braun A; Werth K; Uvarovskii A; Kempf H; Meyer-Hermann M; Arens R; Kremer M; Sutter G; Messerle M; Förster R
    Immunity; 2016 Feb; 44(2):233-45. PubMed ID: 26872694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating CTL mediated killing with a 3D cellular automaton.
    Graw F; Regoes RR
    PLoS Comput Biol; 2009 Aug; 5(8):e1000466. PubMed ID: 19696876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging data.
    Beck RJ; Bijker DI; Beltman JB
    PLoS Comput Biol; 2020 Jul; 16(7):e1007972. PubMed ID: 32658891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Method to Evaluate In Vivo CD8
    Stark FC; Dudani R; Agbayani G; McCluskie MJ
    Methods Mol Biol; 2021; 2183():549-558. PubMed ID: 32959267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
    Huang Y; Shah S; Qiao L
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.
    Nakagawa Y; Negishi Y; Shimizu M; Takahashi M; Ichikawa M; Takahashi H
    Immunol Lett; 2015 Oct; 167(2):72-86. PubMed ID: 26209187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo.
    Asquith B; Edwards CT; Lipsitch M; McLean AR
    PLoS Biol; 2006 Apr; 4(4):e90. PubMed ID: 16515366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression
    Beck RJ; Slagter M; Beltman JB
    Cancer Res; 2019 Jul; 79(13):3406-3416. PubMed ID: 31040155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How T lymphocytes kill infected cells.
    Berke G
    Microbiol Sci; 1985; 2(2):44-6, 51-2. PubMed ID: 3939995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.
    Markasz L; Skribek H; Uhlin M; Otvos R; Flaberg E; Eksborg S; Olah E; Stuber G; Szekely L
    J Immunother; 2008 Apr; 31(3):283-93. PubMed ID: 18317359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
    Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
    Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?
    Wick WD; Yang OO; Corey L; Self SG
    J Virol; 2005 Nov; 79(21):13579-86. PubMed ID: 16227278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
    Weigelin B; Friedl P
    Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes.
    Fan J; Bonavida B
    J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teleost cytotoxic T cells.
    Yamaguchi T; Takizawa F; Furihata M; Soto-Lampe V; Dijkstra JM; Fischer U
    Fish Shellfish Immunol; 2019 Dec; 95():422-439. PubMed ID: 31669897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.